title: Hemofiltration during cardiopulmonary bypass: quality assessment of hemoconcentrated blood.
abstract: Hemofiltration is often used during cardiopulmonary bypass (CPB) for water removal. In a prospective random study 11 patients undergoing elective coronary artery surgery with hemofiltration during CPB were observed and compared to 11 patients without filtration. The quantitative and qualitative aspects of blood before and after filtration while still on CPB and until the first postoperative day were assessed. Intra- and postoperative volume requirements, standard hematology and chemistry, as well as hemolysis, complement activation, and coagulation factors were analysed at nine sequential points in time.
  
  
  RESULTS
  There were no significant differences in pre- and postoperative patient data between the two groups except that the majority of patients in the study group (55%) were anticoagulated and required a significantly longer CPB time with higher doses of protamine and had higher postoperative drainage (2.9 vs. 1.4 L). Intra- and postoperative hemoglobin concentrations, transfusion and volume requirements were similar in both groups. 927 ml of plasma water were filtered during CPB within 4 min 20 s without hemodynamic changes or electrolyte imbalance. Hemoglobin and protein concentrations increased significantly during hemofiltration (Hb increases 3.6 g/dl). Hemolysis and activated complement fractions were elevated during CPB but showed no further increase during filtration; in contrast C4a, C5a, and prothrombin F1 + 2 increased significantly after cessation of CPB. In conclusion, hemofiltration during CPB is a safe and efficient method for water removal and for concentration of red blood cells and proteins without adverse effects on the patient's hemodynamics, blood quality, and volume requirements. More especially, no negative influence of hemofiltration could be determined with regard to activation of the coagulation and complement system.
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, University of Berne, Switzerland.
authors.forename: B H
authors.initials: BH
authors.lastname: Walpoth
authors.forename: T
authors.initials: T
authors.lastname: Amport
authors.forename: R
authors.initials: R
authors.lastname: Schmid
authors.forename: B
authors.initials: B
authors.lastname: Kipfer
authors.forename: M
authors.initials: M
authors.lastname: Lanz
authors.forename: P
authors.initials: P
authors.lastname: Spaeth
authors.forename: G
authors.initials: G
authors.lastname: Kurt
authors.forename: U
authors.initials: U
authors.lastname: Althaus
mesh_terms: D001772:Blood Cell Count; D001774:Blood Chemical Analysis; D001780:Blood Coagulation Tests; D016063:Blood Loss, Surgical; D001804:Blood Transfusion, Autologous / Q000592:standards; D001810:Blood Volume; D002315:Cardiopulmonary Bypass; D001026:Coronary Artery Bypass; D005260:Female; D006440:Hemofiltration; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012189:Retrospective Studies